Search research articles
Contact Us
Filters
Showing results (101-110 of 149) with videos related to
Page
of 15
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2010
Impact of adjuvant treatment modalities on the management of patients with stages I-II endometrial stromal sarcoma
G G Malouf, J Duclos, A Rey, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 26, 2000
Detection of minimal levels of serum anti-Müllerian hormone during follow-up of patients with ovarian granulosa cell tumor by means of a highly sensitive enzyme-linked immunosorbent assay
W Q Long, V Ranchin, P Pautier, et al.
Gynecologie, Obstetrique & Fertilite
|
April 30, 2003
[Surgery for uterine sarcoma: review of the literature and recommendations for the standard surgical procedure]
P Morice, A Rodrigues, P Pautier, et al.
European Journal of Gynaecological Oncology
|
June 17, 2003
Prognostic value of initial surgical procedure for patients with uterine sarcoma: analysis of 123 patients
P Morice, A Rodriguez, A Rey, et al.
British Journal of Cancer
|
May 18, 2026
Clinico-molecular predictors of durable response to immune checkpoint inhibitors (ICI) in metastatic cervical cancer (mCC)
S Barraud, C Roussel-Simonin, P Pautier, et al.
Leukemia & Lymphoma
|
November 8, 2001
Prevention of menstruation with leuprorelin (GnRH agonist) in women undergoing myelosuppressive chemotherapy or radiochemotherapy for hematological malignancies: a pilot study
C Lhommé, P Brault, J H Bourhis, et al.
Gynecologie, Obstetrique & Fertilite
|
May 5, 2004
[Does adenocarcinoma of uterine cervix have a worse prognosis than squamous carcinoma?]
A Recoules-Arche, R Rouzier, A Rey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 15, 2008
Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumor
T de La Motte Rouge, P Pautier, P Duvillard, et al.
Bulletin Du Cancer
|
December 17, 2009
[Rare ovarian tumours: therapeutic strategies in 2010, national website observatory for rare ovarian cancers and delineation of referent centers in France]
I Ray-Coquard, P Pautier, E Pujade-Lauraine, et al.
Bulletin Du Cancer
|
November 19, 2009
[New drugs and targeted therapeutic agents in ovarian cancer]
T de La Motte Rouge, M-C Petrella, J Michels, et al.
Page
of 15
Search research articles
Search
Showing results (101-110 of 149) with videos related to
Sort By:
Page
of 15
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2010
Impact of adjuvant treatment modalities on the management of patients with stages I-II endometrial stromal sarcoma
G G Malouf, J Duclos, A Rey, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 26, 2000
Detection of minimal levels of serum anti-Müllerian hormone during follow-up of patients with ovarian granulosa cell tumor by means of a highly sensitive enzyme-linked immunosorbent assay
W Q Long, V Ranchin, P Pautier, et al.
Gynecologie, Obstetrique & Fertilite
|
April 30, 2003
[Surgery for uterine sarcoma: review of the literature and recommendations for the standard surgical procedure]
P Morice, A Rodrigues, P Pautier, et al.
European Journal of Gynaecological Oncology
|
June 17, 2003
Prognostic value of initial surgical procedure for patients with uterine sarcoma: analysis of 123 patients
P Morice, A Rodriguez, A Rey, et al.
British Journal of Cancer
|
May 18, 2026
Clinico-molecular predictors of durable response to immune checkpoint inhibitors (ICI) in metastatic cervical cancer (mCC)
S Barraud, C Roussel-Simonin, P Pautier, et al.
Leukemia & Lymphoma
|
November 8, 2001
Prevention of menstruation with leuprorelin (GnRH agonist) in women undergoing myelosuppressive chemotherapy or radiochemotherapy for hematological malignancies: a pilot study
C Lhommé, P Brault, J H Bourhis, et al.
Gynecologie, Obstetrique & Fertilite
|
May 5, 2004
[Does adenocarcinoma of uterine cervix have a worse prognosis than squamous carcinoma?]
A Recoules-Arche, R Rouzier, A Rey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 15, 2008
Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumor
T de La Motte Rouge, P Pautier, P Duvillard, et al.
Bulletin Du Cancer
|
December 17, 2009
[Rare ovarian tumours: therapeutic strategies in 2010, national website observatory for rare ovarian cancers and delineation of referent centers in France]
I Ray-Coquard, P Pautier, E Pujade-Lauraine, et al.
Bulletin Du Cancer
|
November 19, 2009
[New drugs and targeted therapeutic agents in ovarian cancer]
T de La Motte Rouge, M-C Petrella, J Michels, et al.
Page
of 15